Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment ContinuesPromising Data, including a 59% Stable ...

Canadian company Medexus Pharmaceuticals recently announced the FDA approval of Grafapex (treosulfan) as part of a conditioning regimen for allogeneic hematopoietic stem cell transplantation. The ...

the number of blast cells has dramatically increased, and leukemia has become more aggressive with noticeable symptoms. This phase is also called the 'blast crisis'. Even though chronic myeloid ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...

The team discovered a unique population of immune cells that is important to the successful treatment of relapsed acute myeloid leukemia (AML). This investigation was done in partnership with the ...

In a paper published today in Science Immunology, the team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML).

The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...

Additional symptoms will develop as leukemic cells start to invade other organs, including the central nervous system (comprised of the brain and spinal cord). Leukemia can broadly be categorized as ...

The findings were published in Science Immunology. "Relapse of AML after stem cell transplant is a major challenge," says first author Katie Maurer, MD, Ph.D.. "There are few effective therapies ...

AML = Acute myeloid leukemia; CK = Complex karyotype; ECOG = Eastern Cooperative Oncology Group; EORTC = European Organization for Research and Treatment of Cancer; GIMEMA = Italian Group for ...